Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary leiomyosarcoma affecting the ankle joint

B M Delsmann1, M Pfahler, A Nerlich

  • 1Orthopaedic Department, Ludwig-Maximilians-University Munich, Klinikum Grosshadern, Germany.

Foot & Ankle International
|July 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hydroxy-chloroquine to treat COVID-19 - infected patients: Some lessons from medical anthropology and history of medicine.

Ethics, medicine, and public health·2020
Same author

Dynamic Virus-Bacterium Interactions in a Porcine Precision-Cut Lung Slice Coinfection Model: Swine Influenza Virus Paves the Way for Streptococcus suis Infection in a Two-Step Process.

Infection and immunity·2015
Same author

Unusual spinal tuberculosis in an Avar Age skeleton (Csongrád-Felgyő, Ürmös-tanya, Hungary): A morphological and biomolecular study.

Tuberculosis (Edinburgh, Scotland)·2015
Same author

[Glenoid replacement for omarthritis : indications, technique, results and new developments].

Der Orthopade·2013
Same author

[Adenocarcinoma of the stomach and neuroendocrine carcinoma of the colon in a 45-year-old male patient suffering from common variable immunodeficiency (CVID) and ulcerative colitis].

Zeitschrift fur Gastroenterologie·2012
Same author

[A rare cause of painless jaundice in a 38-year-old patient].

Zentralblatt fur Chirurgie·2011
Same journal

Two-Stage vs Single-Stage Ilizarov Application in High-Risk Patients: Impact on Early Complications and Resource Utilization.

Foot & ankle international·2026
Same journal

Staging Strategies for the Infected, Deformed Foot.

Foot & ankle international·2026
Same journal

Distal Oblique Osteotomy vs Arthrodesis for Advanced Hallux Rigidus: A Matched Cohort Study.

Foot & ankle international·2026
Same journal

The Incidence of Subtalar Facet Penetration and Its Impact on Clinical and Radiographic Outcome in Lateral Lengthening Calcaneal Osteotomies.

Foot & ankle international·2026
Same journal

Patient-Reported Outcomes and Satisfaction Results on a Modern Fixed-Bearing Total Ankle Arthroplasty: Updated Mean 6-Year Follow-up.

Foot & ankle international·2026
Same journal

Long-term Outcomes After First Metatarsophalangeal Joint Arthrodesis: With Focus on Degenerative Changes on Adjacent Joints.

Foot & ankle international·2026
See all related articles

A rare primary bone leiomyosarcoma in the distal tibia was diagnosed in a patient. Complete surgical removal (R0 resection) is the recommended treatment for this malignant tumor.

Area of Science:

  • Orthopedic Oncology
  • Bone Tumors
  • Soft Tissue Sarcomas

Background:

  • Primary leiomyosarcoma of bone is an exceptionally rare malignant tumor.
  • Accurate diagnosis requires excluding metastatic leiomyosarcoma and utilizing histopathological and immunohistochemical analysis.

Observation:

  • A 50-year-old patient presented with a stage la malignant tumor of the left distal tibia, affecting the ankle joint cartilage.
  • The tumor was diagnosed as a primary bone leiomyosarcoma.

Findings:

  • The diagnosis was confirmed through characteristic histopathological features and immunohistochemical staining.
  • Surgical resection is the primary therapeutic approach for primary bone leiomyosarcoma.

Implications:

Related Experiment Videos

  • Early and accurate diagnosis is crucial for effective management of this rare bone sarcoma.
  • Achieving an R0 resection is essential for optimal patient outcomes in primary bone leiomyosarcoma treatment.